Excess coronary artery disease risk in South Asian immigrants: Can dysfunctional high-density lipoprotein explain increased risk?

References

• AnandSSYusufSVuksanV2000Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE)Lancet3562798411071182
   PubMed Web of Science ®Google Scholar
• AnsellBJFonarowGCFogelmanAM2005High-density lipoprotein function recent advancesJ Am Coll Cardiol461792816286161
   PubMed Web of Science ®Google Scholar
• AnsellBJFonarowGCFogelmanAM2006High-density lipoprotein: is it always atheroprotective?Curr Atheroscler Rep84051116901411
   PubMedGoogle Scholar
• AnsellBJFonarowGCNavabM2007Modifying the anti-inflammatory effects of high-density lipoproteinCurr Atheroscler Rep9576317169248
   PubMedGoogle Scholar
• AnsellBJNavabNHamaS2003Inflammatory/anti-inflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by Simvastatin treatmentCirculation1082751614638544
   PubMed Web of Science ®Google Scholar
• BarterPJBakerPWRyeKA2002Effect of high-density lipoproteins on the expression of adhesion molecules in endothelial cellsCurr Opin Lipidol13285812045398
   PubMed Web of Science ®Google Scholar
• BediUSSinghSSyedA2006Coronary artery disease in South Asians: an emerging risk groupCardiol Rev14748016493244
   PubMedGoogle Scholar
• BhatnagarDAnandISDurringtonPN2005Coronary risk factors in people from the Indian subcontinent living in West London and their siblings in IndiaLancet34540597853948
   PubMedGoogle Scholar
• BhopalRFischbacherCVartiainenE2005Predicted and observed cardiovascular disease in South Asians: application of FINRISK, Framingham and SCORE models to Newcastle Heart Project dataJ Public Health2793100
   Web of Science ®Google Scholar
• BhopalR2002Epidemic of cardiovascular disease in South AsiansBMJ16324
   Google Scholar
• BoekholdtSMSouvereinOWTanckMW2006Common variants of multiple genes that control reverse cholesterol transport together explain only a minor part of the variation of HDL cholesterol levelsClin Genet692637016542392
   PubMed Web of Science ®Google Scholar
• CalabresiLFranceschiniG1997High density lipoprotein and coronary heart disease: Insights from mutations leading to low high density lipoproteinCurr Opin Lipidol8219249253538
   PubMed Web of Science ®Google Scholar
• CastelliWPGarrisonRJWilsonPW1986Incidence of coronary heart disease and lipoprotein cholesterol levels: The Framingham StudyJAMA256283583773200
   PubMed Web of Science ®Google Scholar
• ChhabraSNarangRLakshmyR2005APO A-I 75 G to A substitution associated with severe forms of CAD, lower levels of HDL and Apo A-1 among Northern IndiansDisease Markers211697416403951
   PubMed Web of Science ®Google Scholar
• D’AgostinoRBSrGrundySSullivanLM2001Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigationJAMA286180711448281
   PubMed Web of Science ®Google Scholar
• DodaniSDongYZhuH2008aCan novel Apo A-I polymorphisms be responsible for low HDL in South AsiansIndian J Hum GeneticsIn press
   PubMedGoogle Scholar
• DodaniSKaurRMohammadN2008bCan dysfunctional HDL explain excess risk of coronary artery diseases in South Asian immigrants?Int J Cardiol24Epub ahead of print.
   PubMedGoogle Scholar
• DownsJRClearfieldMWeisS1998Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention StudyJAMA2791615229613910
   PubMed Web of Science ®Google Scholar
• EnasEAGargADavidsonMA1996Coronary heart disease and its risk factors in first-generation immigrant Asian Indians to the United States of AmericaIndian Heart J48343538908818
   PubMedGoogle Scholar
• EnasEAYusufSMehtaJ1992Prevalence of coronary artery disease in Asian IndiansAm J Cardiol7094591529952
   PubMed Web of Science ®Google Scholar
• EnasEA2000Coronary artery disease epidemic in Indians: a cause for alarm and call for actionJ Indian Med Assoc98694511265799
   PubMedGoogle Scholar
• [NCEP ATP III] Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults2001Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA28524869711368702
   PubMed Web of Science ®Google Scholar
• FogelmanAM2004When good cholesterol goes badNat Med10902315340411
   PubMed Web of Science ®Google Scholar
• ForouhiNMcKeigueP1997How far can risk factors account for excess coronary mortality in South Asians?Can J Cardiol1347B
   Google Scholar
• ForouhiNGSattarNTillinT2006Do known risk factors explain the higher coronary heart disease mortality in South Asian compared with European men? Prospective follow-up of the Southall and Brent studiesDiabetologia492580816972045
   PubMed Web of Science ®Google Scholar
• ForouhiNGSattarN2006CVD risk factors and ethnicity – a homogeneous relationship?Atheroscler7119
   PubMed Web of Science ®Google Scholar
• FrankPGMarcelYL2000Apolipoprotein A-I: structure – function relationshipsJ Lipid Res418537210828078
   PubMed Web of Science ®Google Scholar
• GordonDJProbstfieldJLGarrisonRJ1989High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studiesCirculation798152642759
   PubMed Web of Science ®Google Scholar
• GoyalAYusufS2006The burden of cardiovascular disease in the Indian subcontinentIndian J Med Res1242354417085827
   PubMed Web of Science ®Google Scholar
• GrahamAHassallDJRafiqueS1997Evidence for a paraoxonaseindependent inhibition of low-density lipoprotein oxidation by high-density lipoproteinAtherosclerosis1351932049430369
   PubMed Web of Science ®Google Scholar
• GrundySM2002Obesity, metabolic syndrome, and coronary atherosclerosisCirculation1052696812057978
   PubMed Web of Science ®Google Scholar
• GuettierJMGeorgopoulosATsaiMY2005Polymorphisms in the fatty acid-binding protein 2 and apolipoprotein C-III genes are associated with the metabolic syndrome and dyslipidemia in a South Indian populationJ Clin Endocrinol Metab9017051115598690
   PubMed Web of Science ®Google Scholar
• [HPS] Heart Protection Study Collaborative Group.2002MRC/BHF Heart Protection Study of cholesterol lowering with Simvastatin in 20,536 high-risk individuals: a randomized placebo-controlled trialLancet36072212114036
   PubMed Web of Science ®Google Scholar
• HoogeveenRCGambhirJKGambhirDS2001Evaluation of Lp[a] and other independent risk factors for CHD in Asian Indians and their USA counterpartsJ Lipid Res42631811290835
   PubMed Web of Science ®Google Scholar
• HovinghGKBrownlieABisoendialRJ2004A novel apoA-I mutation (L178P) leads to endothelial dysfunction, increased arterial wall thickness, and premature coronary artery diseaseJ Am Coll Cardiol4414293515464323
   PubMed Web of Science ®Google Scholar
• IslamMSRaitakariOTJuonalaM2005Apolipoprotein A-I/C-III/A-IV SstI and apolipoprotein B XbaI polymorphisms and their association with carotid artery intima-media thickness in the Finnish population. The Cardiovascular Risk in Young Finnish StudyAtherosclerosis180798615823278
   PubMed Web of Science ®Google Scholar
• JadhavUMKadamNN2004Apolipoproteins: correlation with carotid intima media thickness and coronary artery diseaseJ Assoc Physicians India52370515656025
   PubMedGoogle Scholar
• JoshiPIslamSPaisP2007Risk factors for early myocardial infarction in South Asians compared with individuals in other countriesJAMA2972869417227980
   PubMed Web of Science ®Google Scholar
• KalhanRPuthawalaKAgarwalS2001Altered lipid profile, leptin, insulin, and anthropometry in offspring of South Asian immigrants in the United StatesMetabolism50119720211586493
   PubMed Web of Science ®Google Scholar
• KarathanasisSK1985Apolipoprotein multigene family: tandem organization of human apolipoprotein AI, CIII, and AIV genesProc Natl Acad Sci U S A82637483931073
   PubMed Web of Science ®Google Scholar
• KlatskyALTekawaIArmstrongMA1994The risk of hospitalization for ischemic heart disease among Asian Americans in northern CaliforniaAm J Public Health84167257943495
   PubMed Web of Science ®Google Scholar
• KobayashiKYYanagiHFukayamaH1998Frequent occurrence of hypoalphalipoproteinemia due to mutant apolipoprotein A-I gene in the population: a population-based surveyHum Mol Genet83316
   Web of Science ®Google Scholar
• KoistinenMJHuikuriHVKorhonenUR1994Asymptomatic coronary artery disease in diabetes: relation to common risk factors, lipoproteins, apolipoproteins and apo E polymorphismActa Diabetol31210147888691
   PubMed Web of Science ®Google Scholar
• KottkeTEThomasRJLopez-JimenezF2006CardioVision 2020: Program acceptance and progress after 4 yearsAm J Prev Med301374316459212
   PubMed Web of Science ®Google Scholar
• KumarAPReynoldsWF2005Statins down regulate myeloperoxidase gene expression in macrophagesBiochem Biophys Res Commun3314425115850779
   PubMed Web of Science ®Google Scholar
• LuepkerRVArnettDKJacobsJR2006Trends in blood pressure, hypertension control, and stroke mortality: the Minnesota Heart SurveyAm J Med11942916431183
   PubMed Web of Science ®Google Scholar
• LusisAJFogelmanAMFonarowGC2004Genetic basis of atherosclerosis: part II: clinical implicationsCirculation11020667115466657
   PubMed Web of Science ®Google Scholar
• MacknessMIArrolSAbbottC1993Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonaseAtherosclerosis104129358141836
   PubMed Web of Science ®Google Scholar
• MaratheGKZimmermanGAMcIntyreTM2003Platelet-activating factor acetylhydrolase, and not paraoxonase-1 is the oxidized phospholipid hydrolase of high density lipoprotein particlesJ Biol Chem27839374712466264
   PubMed Web of Science ®Google Scholar
• McGovernPGPankowJSShaharE1996Recent trends in acute coronary heart disease-mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey InvestigatorsN Engl J Med334884908596571
   PubMed Web of Science ®Google Scholar
• MohanVDeepaRShanthi RaniSS2001Chennai Urban Population Study (CUPS No.5). Prevalence of coronary artery disease and its relationship to lipids in a selected population in South India. The Chennai Urban Population Study (CUPS No. 5)J Am Coll Cardiol38682711527617
   PubMed Web of Science ®Google Scholar
• MollPPMichelVVWeidmanWH1989Genetic determination of plasma apolipoprotein A-I in a population based sampleAm J Hum Genet442439
   Web of Science ®Google Scholar
• NavabMAnantharamaiahGMReddyST2004Human apolipoprotein A-I and A-I mimetic peptides: potential for atherosclerosis reversalCurr Opin Lipidol15645915529023
   PubMed Web of Science ®Google Scholar
• NavabMAnantharamaiahGMReddyST2006Mechanisms of disease: proatherogenic HDL – an evolving fieldNat Clin Pract Endocrinol Metab25041116957764
   PubMedGoogle Scholar
• NavabMAnanthramaiahGMReddyST2005The double jeopardy of HDLAnn Med37173816019715
   PubMed Web of Science ®Google Scholar
• NavabMBerlinerJASubbanagounderG2001HDL and the inflammatory response induced by LDL-derived oxidized phospholipidsArterioscler Thromb Vasc Biol21880
   Web of Science ®Google Scholar
• NavabMHamaSYAnantharamaiahGM2000Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3J Lipid Res41149550810974057
   PubMed Web of Science ®Google Scholar
• NavabMHamaSYCookeCJ2000Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1J Lipid Res4114819410974056
   PubMed Web of Science ®Google Scholar
• NavabMHamaSYHoughGP2001A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipidsJ Lipid Res4213081711483633
   PubMed Web of Science ®Google Scholar
• NordlieMAWoldLEKlonerRA2005Genetic contributors toward increased risk for ischemic heart diseaseJ Mol Cell Cardiol39667916087188
   PubMed Web of Science ®Google Scholar
• Perez-MendezOBruckertEFranceschiniG2000Metabolism of apolipoproteins AI and AII in subjects carrying similar apoAI mutations, apoAI Milano and apoAI ParisAtherosclerosis14831710657568
   PubMed Web of Science ®Google Scholar
• PetersenSPetoVRaynerM2004Coronary heart disease statistics, British Heart FoundationLondon2004[online]. Accessed on February 10, 2008. URL: http://www.heartstats.org/datapage.asp?id=1652
   Google Scholar
• PulkkinenAViitanenLKareinenA2000MspI polymorphism at +83 bp in intron 1 of the human apolipoprotein A1 gene is associated with elevated levels of HDL cholesterol and apolipoprotein A1 in nondiabetic subjects but not in type 2 diabetic patients with coronary heart diseaseDiabetes Care23791510840998
   PubMed Web of Science ®Google Scholar
• RajiAGerhardHWarrenM2004Insulin resistance and vascular dysfunction in non diabetic Asian IndiansJ Clin Endocrinol Metab939657215292334
   PubMedGoogle Scholar
• RemaleyATStonikJADemoskySJ2000Apolipoprotein specificity for lipid efflux by the human ABCA1 transporterBiochem Biophys Res Commun2808182311162594
   PubMed Web of Science ®Google Scholar
• SacksFMPfefferMAMoyeLA1996The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levelsN Engl J Med335100198801446
   PubMed Web of Science ®Google Scholar
• SadafASiddiquiSLestringantGG2002Apolipoprotein AI promoter variant in blood pressure determinationClin Genet613141612030900
   PubMed Web of Science ®Google Scholar
• [SSSG] Scandinavian Simvastatin Survival Group Study1994Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)Lancet344138397968073
   PubMed Web of Science ®Google Scholar
• ShepherdJCobbeSMFordI1995Prevention of coronary heart disease with pravastatin in men with hypercholesterolemiaN Engl J Med333135017566029
   PubMed Web of Science ®Google Scholar
• StampferMJSacksFMSalviniS1991A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarctionN Engl J Med325373812062328
   PubMed Web of Science ®Google Scholar
• TakahashiYSmithJD1999Cholesterol efflux to apolipoprotein AI involves endocytosis and resecretion in a calcium-dependent pathwayProc Natl Acad Sci U S A96113586310500181
   PubMed Web of Science ®Google Scholar
• TillinTForouhiNJohnstonDG2005Metabolic syndrome and coronary heart disease in South Asians, African-Caribbeans and white Europeans: a UK population-based cross-sectional studyDiabetologia486495615759110
   PubMed Web of Science ®Google Scholar
• TulenkoTNSumnerAE2002The physiology of lipoproteinsJ Nucl Cardiol96384912466789
   PubMed Web of Science ®Google Scholar
• UppaluriCR2002Heart disease and its related risk factors in Asian IndiansEthn and Dis124553
   PubMedGoogle Scholar
• WangXLLiuSXMcCredieRM1996Polymorphisms at the 5 prime-end of the apolipoprotein AI gene and severity of coronary artery diseaseJ Clin Invest9837278755647
   PubMed Web of Science ®Google Scholar
• WatsonKEAnsellBJWatsonAD2007HDL Function as a target of lipid-modifying therapyRev Cardiovasc Med81817401296
   PubMed Web of Science ®Google Scholar
• WilliamsB1995Westernized Asians and cardiovascular disease: nature or nurture?Lancet34540127853944
   PubMed Web of Science ®Google Scholar
• WilliamsDLConnellyMATemelRE1999Scavenger receptor B1 and cholesterol traffickingCurr Opin Lipidol103293910482136
   PubMed Web of Science ®Google Scholar
• YanceyPGBortnickAEKellner-WeibelG2003Importance of different pathways of cellular cholesterol effluxArterioscler Thomb Vasc Biol2371219
   PubMed Web of Science ®Google Scholar
• ZhengLNukunaBBrennanML2004Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular diseaseJ Clin Invest1145294115314690
   PubMed Web of Science ®Google Scholar